fluorouracil

Generic: fluorouracil

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fluorouracil
Generic Name fluorouracil
Labeler bluepoint laboratories
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

fluorouracil 50 mg/mL

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-524
Product ID 68001-524_4bbe764b-4bfd-3862-e063-6394a90a7cc0
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210123
Listing Expiration 2027-12-31
Marketing Start 2022-02-18

Pharmacologic Class

Established (EPC)
nucleoside metabolic inhibitor [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001524
Hyphenated Format 68001-524

Supplemental Identifiers

RxCUI
1791701 1791736
UNII
U3P01618RT
NUI
N0000000233 N0000175595

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fluorouracil (source: ndc)
Generic Name fluorouracil (source: ndc)
Application Number ANDA210123 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • 10 VIAL in 1 CARTON (68001-524-30) / 10 mL in 1 VIAL (68001-524-28)
  • 10 VIAL in 1 CARTON (68001-524-31) / 20 mL in 1 VIAL (68001-524-29)
source: ndc

Packages (2)

Ingredients (1)

fluorouracil (50 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "4bbe764b-4bfd-3862-e063-6394a90a7cc0", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["U3P01618RT"], "rxcui": ["1791701", "1791736"], "spl_set_id": ["9c42eeff-ab0c-4820-94d7-e1a3df9fda74"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (68001-524-30)  / 10 mL in 1 VIAL (68001-524-28)", "package_ndc": "68001-524-30", "marketing_start_date": "20220218"}, {"sample": false, "description": "10 VIAL in 1 CARTON (68001-524-31)  / 20 mL in 1 VIAL (68001-524-29)", "package_ndc": "68001-524-31", "marketing_start_date": "20220218"}], "brand_name": "Fluorouracil", "product_id": "68001-524_4bbe764b-4bfd-3862-e063-6394a90a7cc0", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "68001-524", "generic_name": "Fluorouracil", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluorouracil", "active_ingredients": [{"name": "FLUOROURACIL", "strength": "50 mg/mL"}], "application_number": "ANDA210123", "marketing_category": "ANDA", "marketing_start_date": "20220218", "listing_expiration_date": "20271231"}